<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1d3 20150301//EN"  "JATS-archivearticle1.dtd"><article xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article" dtd-version="1.1d3"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn publication-format="electronic">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">76387</article-id><article-id pub-id-type="doi">10.7554/eLife.76387</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Immunology and Inflammation</subject></subj-group></article-categories><title-group><article-title>EROS is a selective chaperone regulating the phagocyte NADPH oxidase and purinergic signalling</article-title></title-group><contrib-group><contrib contrib-type="author" id="author-265623"><name><surname>Randzavola</surname><given-names>Lyra O</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-215586"><name><surname>Mortimer</surname><given-names>Paige M</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-265624"><name><surname>Garside</surname><given-names>Emma</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-265625"><name><surname>Dufficy</surname><given-names>Elisabeth R</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-265626"><name><surname>Schejtman</surname><given-names>Andrea</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-265627"><name><surname>Roumelioti</surname><given-names>Georgia</given-names></name><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-265628"><name><surname>Yu</surname><given-names>Lu</given-names></name><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-265629"><name><surname>Pardo</surname><given-names>Mercedes</given-names></name><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-293221"><name><surname>Spirohn</surname><given-names>Kerstin</given-names></name><xref ref-type="aff" rid="aff5">5</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-265630"><name><surname>Tolley</surname><given-names>Charlotte</given-names></name><xref ref-type="aff" rid="aff6">6</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-265631"><name><surname>Brandt</surname><given-names>Cordelia</given-names></name><xref ref-type="aff" rid="aff6">6</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-265632"><name><surname>Harcourt</surname><given-names>Katherine</given-names></name><xref ref-type="aff" rid="aff7">7</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-293222"><name><surname>Nichols</surname><given-names>Esme</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-265633"><name><surname>Nahorski</surname><given-names>Mike</given-names></name><xref ref-type="aff" rid="aff8">8</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-265634"><name><surname>Woods</surname><given-names>Geoff</given-names></name><xref ref-type="aff" rid="aff8">8</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-60574"><name><surname>Williamson</surname><given-names>James C</given-names></name><xref ref-type="aff" rid="aff9">9</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-265635"><name><surname>Suresh</surname><given-names>Shreehari</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-265636"><name><surname>Sowerby</surname><given-names>John M</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-293223"><name><surname>Matsumoto</surname><given-names>Misaki</given-names></name><xref ref-type="aff" rid="aff10">10</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-295319"><name><surname>Santos</surname><given-names>Celio XC</given-names></name><xref ref-type="aff" rid="aff11">11</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-293225"><name><surname>Kiar</surname><given-names>Cher Shen</given-names></name><xref ref-type="aff" rid="aff12">12</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-265637"><name><surname>Mukhopadhyay</surname><given-names>Subhankar</given-names></name><xref ref-type="aff" rid="aff12">12</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-265638"><name><surname>Rae</surname><given-names>Will M</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-265639"><name><surname>Dougan</surname><given-names>Gordon J</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-148513"><name><surname>Grainger</surname><given-names>John</given-names></name><xref ref-type="aff" rid="aff13">13</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-57098"><name><surname>Lehner</surname><given-names>Paul J</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0001-9383-1054</contrib-id><xref ref-type="aff" rid="aff9">9</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-152356"><name><surname>Calderwood</surname><given-names>Michael A</given-names></name><xref ref-type="aff" rid="aff14">14</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-133481"><name><surname>Choudhary</surname><given-names>Jyoti</given-names></name><xref ref-type="aff" rid="aff15">15</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-13846"><name><surname>Clare</surname><given-names>Simon</given-names></name><xref ref-type="aff" rid="aff6">6</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-265640"><name><surname>Speak</surname><given-names>Anneliese</given-names></name><xref ref-type="aff" rid="aff6">6</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-265641"><name><surname>Santilli</surname><given-names>Giorgia</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-93197"><name><surname>Bateman</surname><given-names>Alex</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-6982-4660</contrib-id><xref ref-type="aff" rid="aff16">16</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-214702"><name><surname>Smith</surname><given-names>Kenneth GC</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-265642"><name><surname>Magnani</surname><given-names>Francesca</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0003-0812-9397</contrib-id><xref ref-type="aff" rid="aff17">17</xref><xref ref-type="corresp" rid="cor1">*</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-215598"><name><surname>Thomas</surname><given-names>David C</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-9738-2329</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="corresp" rid="cor2">*</xref><xref ref-type="other" rid="par-1"/><xref ref-type="fn" rid="conf1"/></contrib><aff id="aff1"><institution content-type="dept">Department of Immunology and Inflammation</institution>, <institution>Imperial College London</institution>, <addr-line><named-content content-type="city">London</named-content></addr-line>, <country>United Kingdom</country></aff><aff id="aff2"><institution content-type="dept">Department of Medicine</institution>, <institution>University of Cambridge</institution>, <addr-line><named-content content-type="city">Cambridge</named-content></addr-line>, <country>United Kingdom</country></aff><aff id="aff3"><institution content-type="dept">Molecular Immunology Unit</institution>, <institution>University College London</institution>, <addr-line><named-content content-type="city">London</named-content></addr-line>, <country>United Kingdom</country></aff><aff id="aff4"><institution content-type="dept">Division of Cancer Biology</institution>, <institution>Institute of Cancer Research</institution>, <addr-line><named-content content-type="city">London</named-content></addr-line>, <country>United Kingdom</country></aff><aff id="aff5"><institution content-type="dept">Center for Cancer Systems Biology</institution>, <institution>Dana-Farber Cancer Institute</institution>, <addr-line><named-content content-type="city">Boston</named-content></addr-line>, <country>United States</country></aff><aff id="aff6"><institution>Wellcome Sanger Institute</institution>, <addr-line><named-content content-type="city">Hinxton</named-content></addr-line>, <country>United Kingdom</country></aff><aff id="aff7"><institution>Wellcome Sanger Institute</institution>, <addr-line><named-content content-type="city">London</named-content></addr-line>, <country>United Kingdom</country></aff><aff id="aff8"><institution content-type="dept">Cambridge Institute of Medical Research</institution>, <institution>University of Cambridge</institution>, <addr-line><named-content content-type="city">Cambridge</named-content></addr-line>, <country>United Kingdom</country></aff><aff id="aff9"><institution content-type="dept">Cambridge Institute for Therapeutic Immunology and Infectious Disease</institution>, <institution>University of Cambridge</institution>, <addr-line><named-content content-type="city">Cambridge</named-content></addr-line>, <country>United Kingdom</country></aff><aff id="aff10"><institution content-type="dept">Department of Pharmacology</institution>, <institution>Kyoto Prefectural University of Medicine</institution>, <addr-line><named-content content-type="city">Kyoto</named-content></addr-line>, <country>Japan</country></aff><aff id="aff11"><institution content-type="dept">School of Cardiovascular Medicine and Sciences</institution>, <institution>King's College London</institution>, <addr-line><named-content content-type="city">London</named-content></addr-line>, <country>United Kingdom</country></aff><aff id="aff12"><institution content-type="dept">Peter Gorer Department of Immunobiology</institution>, <institution>King's College London</institution>, <addr-line><named-content content-type="city">London</named-content></addr-line>, <country>United Kingdom</country></aff><aff id="aff13"><institution content-type="dept">Lydia Becker Institute of Immunology and Inflammation</institution>, <institution>University of Manchester</institution>, <addr-line><named-content content-type="city">Manchester</named-content></addr-line>, <country>United Kingdom</country></aff><aff id="aff14"><institution content-type="dept">Department of Genetics</institution>, <institution>Harvard University</institution>, <addr-line><named-content content-type="city">Boston</named-content></addr-line>, <country>United States</country></aff><aff id="aff15"><institution content-type="dept">Division of Cancer Biol</institution>, <institution>Institute of Cancer Research</institution>, <addr-line><named-content content-type="city">London</named-content></addr-line>, <country>United Kingdom</country></aff><aff id="aff16"><institution content-type="dept">European Bioinformatics Institute</institution>, <institution>European Molecular Biology Laboratory</institution>, <addr-line><named-content content-type="city">Hinxton</named-content></addr-line>, <country>United Kingdom</country></aff><aff id="aff17"><institution content-type="dept">Department of Biology and Biotechnology</institution>, <institution>University of Pavia</institution>, <addr-line><named-content content-type="city">Italy</named-content></addr-line>, <country>Italy</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor" id="author-174088"><name><surname>Yona</surname><given-names>Simon</given-names></name><role>Reviewing editor</role><aff><institution>The Hebrew University of Jerusalem</institution>, <country>Israel</country></aff></contrib></contrib-group><author-notes><corresp id="cor1"><label>*</label>For correspondence: <email>francesca.magnani@unipv.it</email> (FM);</corresp><corresp id="cor2"><label>*</label>For correspondence: <email>david.thomas1@imperial.ac.uk</email> (DT);</corresp></author-notes><pub-date date-type="pub" publication-format="electronic"><day>24</day><month>11</month><year>2022</year></pub-date><volume>11</volume><elocation-id>e76387</elocation-id><history><date date-type="received"><day>15</day><month>12</month><year>2021</year></date><date date-type="accepted"><day>31</day><month>10</month><year>2022</year></date></history><permissions><copyright-statement>Â© 2022, Randzavola et al</copyright-statement><copyright-year>2022</copyright-year><copyright-holder>Randzavola et al</copyright-holder><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link> permitting unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-76387-v1.pdf"/><abstract><p>EROS (Essential for Reactive Oxygen Species) protein is indispensable for expression of gp91<italic>phox</italic>, the catalytic core of the phagocyte NADPH oxidase. EROS deficiency in humans is a novel cause of the severe immunodeficiency, chronic granulomatous disease (CGD), but its mechanism of action was unknown until now. We elucidate the role of EROS, showing it acts at the earliest stages of gp91<italic>phox</italic> maturation. It binds the immature 58kDa gp91<italic>phox</italic> directly, preventing gp91<italic>phox</italic> degradation and allowing glycosylation via the oligosaccharyltransferase (OST) machinery and the incorporation of the heme prosthetic groups essential for catalysis. EROS also regulates the purine receptors P2X7 and P2X1 through direct interactions and P2X7 is almost absent in EROS deficient mouse and human primary cells. Accordingly, lack of murine EROS results in markedly abnormal P2X7 signalling, inflammasome activation and T cell responses. The loss of both ROS and P2X7 signalling leads to resistance to influenza infection in mice. Our work identifies EROS as a highly selective chaperone for key proteins in innate and adaptive immunity and a rheostat for immunity to infection. It has profound implications for our understanding of immune physiology, ROS dysregulation and possibly gene therapy.</p></abstract><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>Mouse</kwd></kwd-group><funding-group><award-group id="par-1"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100010269</institution-id><institution>Wellcome Trust</institution></institution-wrap></funding-source><award-id>098051</award-id><principal-award-recipient><name><surname>Thomas</surname><given-names>David C</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group></article-meta></front><back><sec id="s1" sec-type="additional-information"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interest</title><fn fn-type="conflict" id="conf1"><p>The authors declare that no competing interests exist.</p></fn></fn-group><fn-group content-type="ethics-information"><title>Ethics</title><fn fn-type="other"><p>Animal experimentation: The care and use of all mice were in accordance with UK Home Office regulations (UK Animals Scientific Procedures Act 1986)</p></fn></fn-group></sec><sec id="s2" sec-type="supplementary-material"><title>Additional Files</title><sec id="s3" sec-type="data-availability"><title>Data availability</title><p>The mass spectrometry proteomics data have been deposited to the ProteomeXchange Consortium via the PRIDE partner repository with the dataset identifier &quot;PXD024659&quot;. The plasma membrane profiling mass spectrometry data has the identifier &quot;PXD025149&quot;.</p><p>The following datasets were generated:</p><p><element-citation id="dataset1" publication-type="data" specific-use="isSupplementedBy"><person-group person-group-type="author"><collab>James Wright and Jyoti Choudhary</collab></person-group><year iso-8601-date="2021">2021</year><source>EROS/CYBC1 CONTROLS THE PHAGOCYTE RESPIRATORY BURST VIA DIRECT INTERACTION WITH GP91PHOX AND HAS A NOVEL ROLE IN NLRP3 INFLAMMASOME ACTIVATION</source><ext-link ext-link-type="uri" xlink:href="http://www.ebi.ac.uk/pride/PXD024659">http://www.ebi.ac.uk/pride/PXD024659</ext-link><comment>PRIDE, PXD024659</comment></element-citation><element-citation id="dataset2" publication-type="data" specific-use="isSupplementedBy"><person-group person-group-type="author"><collab>James Williamson and Paul Lehner</collab></person-group><year iso-8601-date="2021">2021</year><source>EROS-mediated control of NOX2 and P2X7 biosynthesi</source><ext-link ext-link-type="uri" xlink:href="http://www.ebi.ac.uk/pride/PXD025149">http://www.ebi.ac.uk/pride/PXD025149</ext-link><comment>PRIDE, PXD025149</comment></element-citation></p></sec><supplementary-material><ext-link xlink:href="elife-76387-supp-v1.zip">Download zip</ext-link><p>Any figures and tables for this article are included in the PDF. The zip folder contains additional supplemental files.</p></supplementary-material></sec></back></article>